Equities

Shandong Weigao Group Medical Polymer Co Ltd

Shandong Weigao Group Medical Polymer Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (HKD)5.16
  • Today's Change0.09 / 1.78%
  • Shares traded8.41m
  • 1 Year change-57.64%
  • Beta0.4651
Data delayed at least 15 minutes, as of May 22 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shandong Weigao Group Medical Polymer Co., Ltd. is principally engaged in the research and development, production and sale of single-use medical devices. The Company sells products under brand names of Jierui and Wego Ortho. The Company operates through three business segments. The Single Use Medical Device Products segment is engaged in the production and sale of single-use consumables, such as infusion sets, syringes, blood transfusion sets and blood bags. The Orthopaedic Products segment is engaged in the production and sale of orthopaedic products. The Blood Purification Products segment is engaged in the production and sale of blood purification products and related medical equipment. The Company is also engaged in the manufacture of industrial automatic equipment and parts, as well as the provision of logistics and storage services through its subsidiaries.

  • Revenue in HKD (TTM)14.26bn
  • Net income in HKD2.16bn
  • Incorporated2000
  • Employees12.52k
  • Location
    Shandong Weigao Group Medical Polymer Co LtdNo.18 Xingshan RoadTorch Hi-Tech Industry Development ZoneWEIHAI 264210ChinaCHN
  • Phone+86 6 315621999
  • Fax+86 6 315621999
  • Websitehttps://www.weigaoholding.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Modern Dental Group Ltd3.17bn404.10m4.79bn7.04k11.901.828.741.510.42450.42453.332.780.84689.105.49450,895.3010.747.0512.608.3453.6150.7712.689.242.5313.170.243839.9812.086.5083.3036.462.42--
Shanghai INT Medical Instruments Co Ltd811.52m168.65m4.88bn1.57k28.172.6522.536.010.98330.98334.7310.450.39042.227.75517,879.607.958.639.499.7658.1959.4420.3526.161.88--0.053531.8028.5029.9618.7921.7645.75--
AK Medical Holdings Ltd1.18bn196.30m6.73bn1.05k34.222.6122.875.710.17530.17531.052.300.37870.84062.381,120,842.006.309.277.5211.2861.6665.0616.6521.782.77--0.043122.653.9712.74-11.074.6721.675.88
Lepu Scientch Mdcl Tchnlgy Shnghi Co Ltd351.30m163.34m6.95bn219.0042.563.3538.7219.790.47110.47111.015.990.17170.584810.301,604,103.007.98--8.25--88.62--46.50--22.93--0.0013--31.58--864.81------
LifeTech Scientific Corp1.37bn283.76m8.43bn1.45k28.752.3244.416.170.06330.06330.30720.78460.30220.749110.46944,638.702.567.093.058.5178.5779.668.4822.692.27--0.14590.0015.4817.88-19.0916.8026.11--
Kangji Medical Holdings Ltd998.20m543.31m9.72bn1.00k17.272.4718.589.740.46330.46330.85123.230.22451.764.76995,218.1010.9714.4012.4516.1880.0481.7548.8457.2417.16--0.01149.6017.7621.235.2828.0041.50--
Angelalign Technology Inc1.59bn57.64m11.97bn2.88k207.133.3282.987.530.34160.34169.4321.290.31945.3316.70551,859.101.055.761.297.5962.3864.333.3013.984.12--0.0188--16.2424.75-74.99-2.2020.54--
MicroPort Scientific Corp7.41bn-3.72bn12.24bn8.23k--2.07--1.65-2.04-2.044.063.220.23991.095.32900,855.30-16.38-11.85-27.68-18.0455.9762.96-68.28-44.431.26-4.210.5477--13.077.27-9.42--19.44--
Shanghai MicroPort MedBot Group Co Ltd112.74m-1.09bn14.51bn650.00--25.92--128.73-1.14-1.140.11760.58420.06230.374642.10173,453.30-60.96---86.19--14.05---978.59--0.8238-11.040.5427--384.16--11.20------
Shanghai Haohai Biological Technology2.84bn448.56m15.01bn2.16k16.191.1722.825.292.632.6316.6636.450.37651.557.501,316,169.005.894.846.865.5070.3472.0915.6516.504.50--0.063536.8625.2711.26130.580.076211.9614.27
Shandong Weigao Group Medical Polymer Co14.26bn2.16bn23.17bn12.52k10.610.95767.241.620.47780.47783.165.290.39452.732.371,139,121.006.157.898.2310.0850.2155.0315.5818.652.1313.090.14830.03-3.778.47-27.576.33-2.93-6.19
Data as of May 22 2024. Currency figures normalised to Shandong Weigao Group Medical Polymer Co Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

13.13%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 09 May 202492.39m2.04%
Norges Bank Investment Managementas of 31 Dec 202391.97m2.03%
Wellington Management Co. LLPas of 30 Apr 202491.44m2.02%
FIL Investment Management (Hong Kong) Ltd.as of 31 Mar 202473.44m1.62%
First Sentier Investors (UK) IM Ltd.as of 31 Jan 202445.67m1.01%
Foresight Fund Management Co., Ltd.as of 30 Jun 202341.85m0.93%
BlackRock Fund Advisorsas of 09 May 202440.96m0.91%
Dimensional Fund Advisors LPas of 09 May 202440.89m0.90%
Allspring Global Investments LLCas of 28 Mar 202438.22m0.85%
BC Investment Management Corp.as of 31 Mar 202336.87m0.82%
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.